BL-7050

N/A

Report date: 2022/08/24 20:00:31

Base Information

Drug NameBL-7050
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPotassium channel modulators
TargetsPotassium channel
Therapy Area/IndicationsPainNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRamot At Tel Aviv University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiolinerx Ltd
Active IndicationsN/A
Inactive IndicationsPainNeuralgia

Other Information

ATC CodeN/A
Related LinksN/A